Literature DB >> 10950787

Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis.

N P Juffermans1, S Florquin, L Camoglio, A Verbon, A H Kolk, P Speelman, S J van Deventer, T van Der Poll.   

Abstract

Interleukin (IL)-1 signaling is required for the containment of infections with intracellular microorganisms, such as Listeria monocytogenes and Leishmania major. To determine the role of IL-1 in the host response to tuberculosis, we infected IL-1 type I receptor-deficient (IL-1R(-/-)) mice, in which IL-1 does not exert effects, with Mycobacterium tuberculosis. IL-1R(-/-) mice were more susceptible to pulmonary tuberculosis, as reflected by an increased mortality and an enhanced mycobacterial outgrowth in lungs and distant organs, which was associated with defective granuloma formation, containing fewer macrophages and fewer lymphocytes, whereas granulocytes were abundant. Lymphocytes were predominantly confined to perivascular areas, suggesting a defective migration of cells into inflamed tissue in the absence of IL-1 signaling. Impaired host defense in IL-1R(-/-) mice was further characterized by a decrease in the ability of splenocytes to produce interferon-gamma. Analysis of these data suggests that IL-1 plays an important role in the immune response to M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950787     DOI: 10.1086/315771

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  103 in total

1.  Simultaneous measurement of antigen-stimulated interleukin-1 beta and gamma interferon production enhances test sensitivity for the detection of Mycobacterium bovis infection in cattle.

Authors:  Gareth J Jones; Chris Pirson; R Glyn Hewinson; H Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Interleukin-1 and host control of pulmonary histoplasmosis.

Authors:  George S Deepe; Michael McGuinness
Journal:  J Infect Dis       Date:  2006-08-10       Impact factor: 5.226

Review 3.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

4.  Altered CD8(+) T cell frequency and function in tuberculous lymphadenitis.

Authors:  Nathella Pavan Kumar; Rathinam Sridhar; Luke Elizabeth Hanna; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Subash Babu
Journal:  Tuberculosis (Edinb)       Date:  2014-07-01       Impact factor: 3.131

Review 5.  Autophagy in the immune response to tuberculosis: clinical perspectives.

Authors:  C Ní Cheallaigh; J Keane; E C Lavelle; J C Hope; J Harris
Journal:  Clin Exp Immunol       Date:  2011-03-25       Impact factor: 4.330

6.  Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis.

Authors:  Wen-Lin Su; Wann-Cherng Perng; Ching-Hui Huang; Cheng-Yu Yang; Chin-Pyng Wu; Jenn-Han Chen
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

7.  Pathological and immunological profiles of rat tuberculosis.

Authors:  Isamu Sugawara; Hiroyuki Yamada; Satoru Mizuno
Journal:  Int J Exp Pathol       Date:  2004-06       Impact factor: 1.925

8.  Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination.

Authors:  Sara B Cohen; Benjamin H Gern; Jared L Delahaye; Kristin N Adams; Courtney R Plumlee; Jessica K Winkler; David R Sherman; Michael Y Gerner; Kevin B Urdahl
Journal:  Cell Host Microbe       Date:  2018-08-23       Impact factor: 21.023

Review 9.  Interleukin-1 function and role in rheumatic disease.

Authors:  Georg Schett; Jean-Michel Dayer; Bernhard Manger
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

10.  In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs.

Authors:  Irina V Lyadova; Evgeny N Tsiganov; Marina A Kapina; Galena S Shepelkova; Vasily V Sosunov; Tatiana V Radaeva; Konstantin B Majorov; Natalya S Shmitova; Henk-Jan van den Ham; Vitaly V Ganusov; Rob J De Boer; Rachael Racine; Gary M Winslow
Journal:  PLoS One       Date:  2010-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.